Evidence map›Paper›PMID 37275890›Full record

ArticleFrontiers in immunology2023

Potential of algae-derived alginate oligosaccharides and β-glucan to counter inflammation in adult zebrafish intestine.

Saima Rehman, Adnan H Gora, Yousri Abdelhafiz, Jorge Dias, Ronan Pierre, Koen Meynen, Jorge M O Fernandes, Mette Sørensen, Sylvia Brugman, Viswanath Kiron

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Microencapsulation ofFrontiers in microbiology · 2026
    Article
  4. Review
  5. First Report onAquaculture nutrition · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Brewers' Yeast (Aquaculture nutrition · 2025
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Saima RehmanFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Adnan H GoraFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Yousri AbdelhafizFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Jorge DiasSPAROS Lda, Olhão, Portugal.
Ronan PierreCEVA (Centre d'Etude et de Valorisation des Algues), Pleubian, France.
Koen MeynenKemin Aquascience, Division of Kemin Europa N.V., Herentals, Belgium.
Jorge M O FernandesFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Mette SørensenFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Sylvia BrugmanAnimal Sciences Group, Host Microbe Interactomics, Wageningen University and Research, Wageningen, Netherlands.
Viswanath KironFaculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Nord University · NOCentre d’Étude et de Valorisation des Algues · FRKemin (Belgium) · BESparos (Portugal) · PTWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alginate oligosaccharides (AOS) are natural bioactive compounds with anti-inflammatory properties. We performed a feeding trial employing a zebrafish (

Indexed as

beta-GlucansZebrafishAnimalsGlycine maxInflammationIntestinesOligosaccharidesbeta-GlucansOligosaccharidesgutmacroalgaemetabolomicsmicroalgaeprebioticsRNA seqβ-glucans

Identifiers

PMID37275890
PMCPMC10235609
OpenAlexW4377137758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.